Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid Dosing in Open-Heart Surgery
NCT04996368Completed
- Sponsor
- Shahid Gangalal National Heart Centre
- Start
- Feb 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in hemorrhage (2 arms), sponsored by Shahid Gangalal National Heart Centre. Primary endpoint: Amount of blood loss at 24 hours. Started Feb 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT04996368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04996368.